|
CURX Curanex Pharmaceuticals Inc 2025942 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,290,970.00 |
| Balance Sheet |
|
Current Assets
|
$4,792,993.00 |
|
Assets
|
$5,073,932.00 |
|
Current Liabilities
|
$104,306.00 |
|
Liabilities
|
$286,254.00 |
|
Equity
|
$4,787,678.00 |
|
Shares Out
|
28364812.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,034,671.00 |
| Market Analysis |
Market Cap
|
$149,482,559.24 |
|
Price
|
$5.27 |
|
BVPS
|
0.17 |
|
PB
|
31.00 |
|
EPS
|
-0.12 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:01 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:51 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CURX documents filed with the SEC.
CURX Filings
Clear
